CBDepot
Natural Cannabinoid Ingredients for Pharmaceutical Products
Pfizer has received approval from the US Food and Drug Administration (FDA) for Geodon capsules as part of a combination maintenance treatment for bipolar disorder in adults. The FDA has approved Geodon for the treatment of bipolar 1 disorder as an adjunct to lithium or valproate in adu
Pfizer has received approval from the US Food and Drug Administration (FDA) for Geodon capsules as part of a combination maintenance treatment for bipolar disorder in adults.
The FDA has approved Geodon for the treatment of bipolar 1 disorder as an adjunct to lithium or valproate in adults.
Bipolar disorder affects about 5.7 million adults in the US and needs lifelong treatment and management.
Geodon is also FDA-approved for the treatment of acute manic and mixed episodes associated with bipolar disorder, with or without psychotic features, and for the treatment of schizophrenia.
Natural Cannabinoid Ingredients for Pharmaceutical Products
Fully Automated Temperature Monitoring for the Pharmaceutical Industry
Filtration & Separation Solutions for Purifying Active Pharmaceutical Ingredients